TY - JOUR
T1 - SCH00013, a novel Ca2+ sensitizer with positive inotropic and no chronotropic action in heart failure
AU - Tadano, Naoto
AU - Morimoto, Sachio
AU - Yoshimura, Akira
AU - Miura, Makoto
AU - Yoshioka, Kimitomo
AU - Sakato, Mitsuo
AU - Ohtsuki, Iwao
AU - Miwa, Yoshikazu
AU - Takahashi-Yanaga, Fumi
AU - Sasaguri, Toshiyuki
PY - 2005/1
Y1 - 2005/1
N2 - We investigated the effects of the agent SCH00013 on Ca2+- induced force generation in rabbit skinned cardiac muscle fibers and in vivo cardiac function in high-pacing-induced heart failure dogs. The Ca 2+-induced force generation in skinned cardiac muscle fibers was determined at pH 6.2-7.4, and SCH00013 was found to have a significant Ca 2+ sensitizing effect at pH 7.2 to 7.4. There was no significant difference in the Ca2+ sensitizing action between the enantiomers of SCH00013. The Ca2+ sensitizing effect of SCH00013 was dependent on the sarcomere length, being significant only at a long sarcomere length. SCH00013 elicited a positive inotropic effect at more than 0.3 and 1 mg/kg, i.v. in normal and heart failure dogs, respectively, with no chronotropic action. These results strongly suggested that SCH00013 is a novel Ca2+ sensitizer that elicits a positive inotropic and no chronotropic effect in heart failure, probably through enhancing the Frank-Starling mechanism.
AB - We investigated the effects of the agent SCH00013 on Ca2+- induced force generation in rabbit skinned cardiac muscle fibers and in vivo cardiac function in high-pacing-induced heart failure dogs. The Ca 2+-induced force generation in skinned cardiac muscle fibers was determined at pH 6.2-7.4, and SCH00013 was found to have a significant Ca 2+ sensitizing effect at pH 7.2 to 7.4. There was no significant difference in the Ca2+ sensitizing action between the enantiomers of SCH00013. The Ca2+ sensitizing effect of SCH00013 was dependent on the sarcomere length, being significant only at a long sarcomere length. SCH00013 elicited a positive inotropic effect at more than 0.3 and 1 mg/kg, i.v. in normal and heart failure dogs, respectively, with no chronotropic action. These results strongly suggested that SCH00013 is a novel Ca2+ sensitizer that elicits a positive inotropic and no chronotropic effect in heart failure, probably through enhancing the Frank-Starling mechanism.
UR - http://www.scopus.com/inward/record.url?scp=20044373810&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20044373810&partnerID=8YFLogxK
U2 - 10.1254/jphs.FP0040654
DO - 10.1254/jphs.FP0040654
M3 - Article
C2 - 15644593
AN - SCOPUS:20044373810
SN - 1347-8613
VL - 97
SP - 53
EP - 60
JO - Journal of Pharmacological Sciences
JF - Journal of Pharmacological Sciences
IS - 1
ER -